Skip to content

Exploring Traditional Medicine: Darvyadi Kwath and Triphala Kashaya for Shwetapradar or Abnormal white discharge treatment

A Clinical study to Evaluate the Efficacy of Darvyadi Kwath and Triphala Kashaya in the Management of Shwetaprdara - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067899
Enrollment
30
Registered
2024-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

None listed

Sponsors

Government Ayurvedic College and Hospital Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing for trial Patient having complaints of mucoid vaginal discharge, white/thin watery discharge and itching per vaginum along with symptoms like backache

Exclusion criteria

Exclusion criteria: Purulent and blood stained vaginal discharge. All Sexually transmitted disease like V.D.R.L , AIDS. Patient suffering from chronic diseases like Cancer of any genital organs, Tuberculosis, Cardiac complications Uterine fibroids, Endometrial polyp, Adenomyosis Patient having Diabetes, CKD, Hypertension Patient using with IUCDs

Design outcomes

Primary

MeasureTime frame
In reducing symptoms associated with Shwetapradar, including abnormal vaginal discharge, itching per vaginum, and discomfort.Timepoint: 2 month

Secondary

MeasureTime frame
Comparison of the efficacy of Darvyadi Kwath & Triphala Kashaya with conventional treatments for Shwetapradar, providing insights into their relative effectiveness & potential advantages or disadvantages.Timepoint: 2 month

Countries

India

Contacts

Public ContactDr Shweta

Government Ayurvedic College and Hospital, Patna

shwetacbpac@gmail.com9560082204

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026